THERAPY DOSSIER · th-aa1eb321f4a1

Neuromuscular electrical stimulation

Device

Evidence & regulatory context

Mechanism: Not recorded
Target: Not recorded
Injury models: Other
Reported indication: Not recorded
First approval: Not recorded
Development stage: Not recorded
ChEMBL record: Not recorded
ChEMBL max phase: Not recorded
Synonyms: Not recorded
Note: Not recorded

Clinical trials 5

5 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.

NCT05249985 ↗Injury indicationNAcompleted

Effects of Protein Supplementation and Neuromuscular Electrical Stimulation on Fat-free Mass in Persons With Motor Complete Spinal Cord Injury: a Pilot Study

Spinal Cord Injuries

Enrolment: 30 · Results not recorded

NCT05888714 ↗Injury indicationNAunknown

Pilot Study for Peripheral Neuromuscular Electrical Stimulation of the Quadriceps Muscle

Spinal Cord Injuries · Brain Injuries · Muscle Atrophy

Enrolment: 15 · Results not recorded

NCT07099911 ↗Injury indicationNArecruiting

Novel Use of Neuromuscular Electrical Stimulation to Improve Glucose Control in Individuals With Spinal Cord Injury

Spinal Cord Injury

Enrolment: 20 · Results not recorded

NCT02427230 ↗Injury indicationNAcompleted

The Effect of Pelvic Floor Muscle Training and Neuromuscular Electrical Stimulation on Urinary Incontinence and Quality of Life in Women With Spinal Cord Injury

Spinal Cord Injury · Urinary Incontinence

Enrolment: 27 · Results not recorded

NCT04914975 ↗Injury indicationNAcompleted

The Effect of Neuromuscular Electrical Stimulation on Bowel Management in People With Chronic Spinal Cord Injury - a Pilot Study

Electric Stimulation Therapy · Bowel Dysfunction · Spinal Cord Injuries · Defecation Disorder

Enrolment: 20 · Results not recorded

Preclinical evidence 1

1 studies reported at therapy level; 1 evidence entries itemised.

PMID 23625381 ↗2013Mixed findings

Neuromuscular electrical stimulation alters gene expression and delays quadriceps muscle atrophy of rats after anterior cruciate ligament transection.

RatOtherWistarMaleApplied in the acute phase after anterior cruciate ligament transection

Model: Anterior cruciate ligament transection with resulting quadriceps muscle atrophy

Stimulation reduced accumulation of atrogene and myostatin mRNA and prevented loss of muscle mass at 3 days, but did not prevent atrophy at 7 or 15 days after transection.

Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.

Loading the evidence…